0 results for ''Barroway Topaz Kessler''
$3 Mil. Verdict Tossed In CLC's First Hormone-Therapy Case
Philadelphia's juries seem to be persuaded by the arguments presented by hormone therapy litigation plaintiffs in their products liability actions against a locally based pharmaceuticals giant, but the city's judges don't.Firms vie for lead roles in big litigation
The Toyota litigation is the latest high-profile case to attract a set of plaintiffs' securities firms that have become increasingly competitive regulars in the fight for lead counsel status in big-ticket shareholder litigation.Firms Vie for Lead Roles in Big Litigation
When shareholder class actions began rolling in against Toyota Motor Corp., senior partners from more than a half-dozen of the nation's most prominent law firms piled into a Los Angeles courtroom to make their case for lead counsel status. Among them were lawyers from Robbins Geller Rudman & Dowd and Labaton Sucharow. In the end, Gerald Silk, a partner at New York's Bernstein Litowitz Berger & Grossmann, accepted the coveted position.Drought Ends for Securities Class Action Settlements
Securities class action settlements rebounded slightly in 2009 after experiencing a significant decline in 2008. That is the key finding of a report released Wednesday by Cornerstone Research, an economic and financial consulting firm. The report tracked 103 such court-approved settlements in 2009, up slightly from 97 in 2008. The total value of securities class action settlements grew by more than 35 percent, from $2.75 billion in 2008 to $3.8 billion in 2009.Decline in 2008 securities class actions
Last year there were fewer settlements in securities class actions than 2007, average recoveries dropped, and new plaintiffs' firms emerged in leadership roles, according to a new study by Cornerstone Research. In addition, the report, released today, found that the effect of corporate earnings restatements has declined since the passage of the Sarbanes-Oxley Act so that it currently has no impact on settlement amounts.$3M verdict tossed in hormone therapy case
Philadelphia's juries seem to be persuaded by the arguments presented by hormone therapy litigation plaintiffs in their products liability actions against a locally based pharmaceuticals giant, but the city's judges don't. A ruling Wednesday by a judge granting the defense judgment NOV in Nelson v. Wyeth means that the first hormone therapy case to reach trial in the city's Complex Litigation Center has effectively ended with a Wyeth victory despite a sizable jury award in favor of the plaintiffs.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Blueprint for Successful Second Request Document Review
Brought to you by Integreon
Download Now
Employee Happiness Playbook: The 3 R's for Business Success in 2024
Brought to you by Amazing Workplace, Inc.
Download Now
The Positive Impact of AI at Small Law Firms: 4 Key Insights
Brought to you by LexisNexis®
Download Now
Will Generative AIs Transform Legal Services? Defensibility and Security Must Be a Focus
Brought to you by HaystackID
Download Now